These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8033122

  • 1. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.
    Mineta T, Rabkin SD, Martuza RL.
    Cancer Res; 1994 Aug 01; 54(15):3963-6. PubMed ID: 8033122
    [Abstract] [Full Text] [Related]

  • 2. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 3. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.
    Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA.
    Cancer Res; 1994 Nov 15; 54(22):5745-51. PubMed ID: 7954393
    [Abstract] [Full Text] [Related]

  • 4. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
    Yamamura H, Hashio M, Noguchi M, Sugenoya Y, Osakada M, Hirano N, Sasaki Y, Yoden T, Awata N, Araki N, Tatsuta M, Miyatake SI, Takahashi K.
    Cancer Res; 2001 May 15; 61(10):3969-77. PubMed ID: 11358814
    [Abstract] [Full Text] [Related]

  • 5. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 6. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N, Kuriyama H, Julin CM, Lamborn KR, Israel MA.
    Cancer Res; 2001 Mar 01; 61(5):1805-9. PubMed ID: 11280727
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC.
    Mol Ther; 2000 Aug 01; 2(2):114-20. PubMed ID: 10947938
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY, Roizman B, Whitley RJ.
    Cancer Res; 1997 Apr 15; 57(8):1502-9. PubMed ID: 9108452
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model.
    Cullinan AE, Lindstrom MJ, Sabet S, Albert DM, Brandt CR.
    Curr Eye Res; 2004 Apr 15; 29(2-3):167-72. PubMed ID: 15512963
    [Abstract] [Full Text] [Related]

  • 10. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL.
    Cancer Gene Ther; 1999 Apr 15; 6(4):358-66. PubMed ID: 10419054
    [Abstract] [Full Text] [Related]

  • 11. Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.
    Nawa A, Nozawa N, Goshima F, Nagasaka T, Kikkawa F, Niwa Y, Nakanishi T, Kuzuya K, Nishiyama Y.
    Gynecol Oncol; 2003 Oct 15; 91(1):81-8. PubMed ID: 14529666
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
    Rainov NG, Dobberstein KU, Heidecke V, Dorant U, Chase M, Kramm CM, Chiocca EA, Breakefield XO.
    Cancer Gene Ther; 1998 Oct 15; 5(3):158-62. PubMed ID: 9622099
    [Abstract] [Full Text] [Related]

  • 13. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
    Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO.
    Mol Ther; 2000 Apr 15; 1(4):347-57. PubMed ID: 10933953
    [Abstract] [Full Text] [Related]

  • 14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 15. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.
    Cancer Res; 2003 May 15; 63(10):2462-9. PubMed ID: 12750267
    [Abstract] [Full Text] [Related]

  • 16. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
    Izquierdo M, Martín V, de Felipe P, Izquierdo JM, Pérez-Higueras A, Cortés ML, Paz JF, Isla A, Blázquez MG.
    Gene Ther; 1996 Jun 15; 3(6):491-5. PubMed ID: 8789798
    [Abstract] [Full Text] [Related]

  • 17. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Jun 15; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 18. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 15; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 19. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 15; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 20. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
    Hoshi M, Harada A, Kawase T, Uyemura K, Yazaki T.
    Cancer Gene Ther; 2000 May 15; 7(5):799-805. PubMed ID: 10830727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.